FCM
OCDX

Farallon Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Farallon Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,426,913
Closed -$45.3M – 337
2022
Q1 		$45.3M Buy
+2,426,913
New +$43.7M 0.22% 71

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farallon Capital Management's OCDX Position: Q2 2022 in Review

Farallon Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 2,426,913 shares — an estimated $45.3M sold.

Farallon Capital Management first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $45.3M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Farallon Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Farallon Capital Management sold 2,426,913 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $45.3M.
  • Farallon Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Farallon Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $45.3M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.